查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1857634

NGS样品製备市场按产品类型、应用、技术、工作流程步骤和最终用户划分－全球预测，2025-2032年

NGS Sample Preparation Market by Product Type, Application, Technology, Workflow Step, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，NGS 样品製备市场将成长至 94.5 亿美元，复合年增长率为 16.52%。

关键市场统计数据
基准年 2024 27.8亿美元
预计年份：2025年 32.4亿美元
预测年份 2032 94.5亿美元
复合年增长率 (%) 16.52%

阐明为何优化次世代定序仪的样本製备是一项能够提升资料品质、工作流程效率和增强竞争优势的策略能力。

次世代定序仪样本製备是一项基础性技术，它决定了研究、临床和工业应用中数据的完整性、週转速度和下游分析的准确性。过去十年，试剂、工作流程和自动化技术的不断改进，持续缩短了定序週期，并扩展了其应用范围，从标靶定序到全基因组和元基因组分析。在此背景下，样品製备不再是常规的上游工序，而是一项策略性能力，对整个定序计画的通量、可重复性和成本效益有显着影响。

解释正在重塑各实验室样品製备工作流程和供应商优先事项的技术、操作和应用主导转变。

次世代定序仪的样本製备格局正经历多重变革，这些变革的驱动力包括技术创新、终端用户需求的变化以及监管环境的调整。酵素工程和化学领域的进步使得片段化和文库建构化学方法能够可靠地处理低起始量、劣化和保存的样本；而微流体和液滴技术则为常规工作流程带来了小型化和并行化。这些技术变革与日益增长的自动化和封闭式系统解决方案的重视相辅相成，这些解决方案能够减少操作人员的差异，并加快结果的获取速度，尤其对于寻求提高诊断通量的临床实验室而言。

分析随着美国关税变化和贸易政策调整，供应链摩擦、采购复杂性和区域韧性如何成为2025年更重要的优先事项。

2025年美国关税和贸易政策调整的累积效应，为样品製备试剂、塑胶和仪器的全球供应链带来了新的摩擦。更高的进口关税和更严格的分类要求增加了部分硬体组件和特殊耗材的到岸成本，迫使采购团队必须寻求供应商多元化，重新评估库存策略和合约条款。同时，海关合规要求也要求更详细的产品编码和文件记录，这不仅延长了关键产品的前置作业时间，还增加了供应商和买家的行政成本。

建立多轴细分框架，将产品类型、应用、技术、工作流程步骤和最终用户画像与策略性产品和商业化选择连结起来。

一个连贯的细分框架揭示了样本製备领域的多维特性，并阐明了创新与需求的交会点。从产品类型来看，市场涵盖扩增试剂盒、片段化和大小选择解决方案、文库建构试剂盒以及标靶富集试剂盒。扩增试剂盒包括传统PCR方法、数位PCR和qPCR，以及使用锁定探针的滚环扩增和基于phi29的方法。片段化和大小选择策略分为酵素片段化（区分内切酶和转座酶方法）和机械片段化方法，例如常用的超音波平台。文库建构提供RNA特异性工作流程（包括mRNA、小RNA和总RNA试剂盒）、针对遗传疾病和肿瘤panel的标靶文库建构方法，以及从无PCR到标准全基因组定序(WGS)建构的各种全基因组文库建构试剂盒。标靶富集分为基于扩增子的方法（包括多重和单重 PCR）和杂合反应捕获策略（利用阵列或溶液形式）。

探讨区域供应链架构、管理体制和终端用户成熟度将如何影响产品采用、支援模式和商业化策略。

区域动态将对样品製备技术的应用、监管和商业化产生决定性影响。美洲拥有强大的学术研究能力和密集的诊断实验室网络，这推动了对高通量自动化技术和支援临床验证的专用试剂盒的需求。转化研究的投资以及成熟的私人生物技术产业奖励供应商提供整合解决方案，以简化监管申报和实验室认证流程。此外，靠近主要製造商和区域分销中心通常可以缩短前置作业时间并改善售后服务。

透过专有化学技术、自动化相容性、服务模式以及供应商之间的策略伙伴关係关係来评估竞争差异化

活跃于样品製备领域的公司之间的竞争动态，体现在深厚的技术实力、广泛的检验工作流程以及为客户提供全生命週期服务的能力之间。领先企业透过专有化学技术、自动化整合和品管解决方案来降低变异性并加速验证，从而实现差异化。试剂供应商和仪器製造商之间的伙伴关係日益普遍，以创造出捆绑式解决方案，简化了高通量临床和商业定序实验室的采购流程。同时，规模较小的专业公司则专注于特定领域的化学技术，例如针对低起始量或受损DNA优化的酵素製剂，或能够实现独特样品处理功能的微流体系统。

为采购、研发和实验室负责人处方笺措施，以加强供应链韧性、加快验证速度并优化定序工作流程的技术应用。

定序与样品製备负责人必须采取务实的多层次策略，使技术选择与营运弹性及科研目标一致。首先，采购团队应扩展供应商资质标准，纳入供应链透明度、区域库存能力以及已记录的紧急时应对计画，以减少对单一供应商的依赖，并最大限度地减少验证中断。同时，研发和实验室负责人应优先验证模组化工作流程，在可行的情况下进行组件级等效性测试，并在不影响资料品质的前提下加快采用替代供应商。

描述一种混合方法研究途径，该方法整合了相关人员访谈、技术文献综合以及交叉检验的产品和工作流程映射，以得出可靠的结论。

本分析的研究途径结合了结构化的原始资讯、有针对性的二手资讯综合以及严格的交叉检验。原始资料收集包括对学术界、临床界和商业领域的实验室主任、采购负责人和技术负责人进行深度访谈，以了解营运限制、检验实践和技术偏好。这些访谈旨在突显吞吐量、灵敏度和周转时间之间的实际权衡，并确定应对供应链中断的切实可行的缓解措施。

总结为什么将样品製备视为战略能力对于确保数据完整性、运行弹性和持续的科学进步至关重要。

总之，次世代定序仪的样本製备已从一系列独立的实验室任务发展成为一个策略性领域，对定序速度、可重复性和结果可解释性有显着影响。酵素化学、片段化策略、微流体和自动化等领域的技术进步，不仅拓展了适用于高品质定序的检体范围，也使实验室能够降低变异性并扩大营运规模。同时，贸易政策的转变和区域格局的演变，凸显了多元化供应链、本地支援和供应商透明度在营运中的必要性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 整合微流体平台实现单细胞NGS库製备自动化，提高通量并减少试剂用量
  • 利用酵素片段化试剂盒简化DNA脱落过程，提高NGS工作流程的定序均一性
  • 开发一种以微珠为基础的高通量、可扩展的NGS库纯化和精确片段大小选择纯化系统
  • 实施自动化端到端NGS样品製备解决方案，以最大限度地减少人为错误并缩短週转时间
  • 新兴的基于条码转座酶的标籤化方法可用于经济高效的多重NGS库构建

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的NGS样品製备市场

  • 放大套件
    • PCR试剂盒
      • 常规PCR试剂盒
      • 数位PCR试剂盒
      • 定量PCR试剂盒
    • 滚动循环放大
      • 挂锁探针底座
      • Phi29 基体
  • 碎片化和尺寸选择
    • 酵素断裂
      • 基于核酸内切酶
      • 基于转座酶
    • 机械破碎
      • 生物掠食者
      • 协变数
  • 图书馆准备工具包
    • RNA文库製备
      • mRNA试剂盒
      • 小RNA试剂盒
      • 总RNA试剂盒
    • 目标文库构建
      • 遗传疾病检测
      • 肿瘤专家组
    • 全基因组文库构建
      • 无需PCR的试剂盒
      • 标准WGS试剂盒
  • 靶向序列捕获盒
    • 扩增子富集
      • 多重PCR
      • 单重PCR
    • 杂合反应捕获
      • 基于数组
      • 基于解决方案

9. 按应用分類的NGS样品製备市场

  • 表观遗传学
    • 亚硫酸氢盐测序
    • ChIP定序
  • 总体基因体学
    • 16S rRNA测序
    • 霰弹枪式宏基因体学
  • RNA定序
    • miRNA定序
    • mRNA定序
    • 总RNA定序
  • 标靶定序
    • 遗传性疾病
    • 肿瘤学
    • 药物基因体学
  • 全基因组定序

第十章 依技术分類的NGS样品製备市场

  • 以微珠为基础
    • 磁珠
    • 固相珠
  • 基于酵素的
    • 连接酶
    • 限制性内切酶
    • 转座酶
  • 微射流
    • 基于液滴的
    • 实验室晶片
  • 基于PCR的
    • 常规PCR
    • 数位PCR
    • QPCR

11. 依工作流程步骤分類的NGS样品製备市场

  • 放大
    • PCR扩增
    • 滚动圆圈
  • 集中
    • 扩增子
    • 杂合反应
  • 碎片化
    • 酵素
    • 机械的
  • 图书馆准备
    • RNA製备
    • 目标准备
    • 全基因组定序 (WGS) 製备
  • 定量和品质控制
    • 电泳
    • 萤光分析

第十二章：依最终用户分類的NGS样品製备市场

  • 学术和政府机构
  • 合约研究组织
  • 诊断实验室
  • 製药和生物技术

第十三章 各地区NGS样品製备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 按组别分類的NGS样品製备市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国NGS样品製备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • QIAGEN NV
    • Roche Diagnostics International Ltd.
    • Agilent Technologies, Inc.
    • New England Biolabs, Inc.
    • Takara Bio Inc.
    • PerkinElmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Promega Corporation
    • Merck KGaA
    • BGI Genomics Co., Ltd.
    • Promega Corporation
    • Sysmex Corporation
    • Novogene Co., Ltd.
Product Code: MRR-9F52358C4167

The NGS Sample Preparation Market is projected to grow by USD 9.45 billion at a CAGR of 16.52% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.78 billion
Estimated Year [2025] USD 3.24 billion
Forecast Year [2032] USD 9.45 billion
CAGR (%) 16.52%

Establishing why optimized sample preparation for next-generation sequencing is a strategic capability that drives data quality, workflow efficiency, and competitive differentiation

Next-generation sequencing sample preparation is the foundational discipline that determines data integrity, turnaround speed, and downstream analytical fidelity across research, clinical, and industrial applications. Over the past decade, incremental improvements in reagents, workflows, and automation have steadily compressed cycle times while expanding the range of applications from targeted panels to whole-genome and metagenomic assays. In this context, sample preparation is no longer a routine upstream task; it is a strategic capability that can materially influence overall throughput, reproducibility, and the cost-efficiency of sequencing programs.

Consequently, laboratories and organizations that invest deliberately in optimized sample preparation protocols-spanning fragmentation, amplification, library preparation, enrichment, and quantification-realize disproportionate gains in data quality and operational resilience. As sequencing platforms continue to diversify and customers demand higher sensitivity and lower input requirements, the role of sample preparation vendors, integrators, and internal process owners gains prominence. This introduction frames the subsequent analysis by emphasizing that strategic choices in reagents, hardware, and workflow design directly shape scientific outcomes and commercial competitiveness.

Explaining the technological, operational, and application-driven shifts that are reshaping sample preparation workflows and supplier priorities across laboratories

The landscape of sample preparation for next-generation sequencing is undergoing several transformative shifts driven by technological innovation, changing end-user demands, and evolving regulatory expectations. Advances in enzyme engineering and chemistry have enabled fragmentation and library-preparation chemistries that work reliably with lower-input, degraded, and archival samples, while microfluidics and droplet-based approaches have brought miniaturization and parallelization to routine workflows. These technological shifts are complemented by a rising emphasis on automation and closed-system solutions that reduce operator variability and accelerate time-to-result, particularly for clinical laboratories seeking to scale diagnostic throughput.

At the same time, the application spectrum is broadening: RNA sequencing applications are moving beyond bulk mRNA profiling into small RNA and total RNA characterization, and targeted enrichment methods are increasingly tailored for oncology, inherited-disease panels, and pharmacogenomics. Epigenetics and metagenomics workflows are benefiting from specialized conversion chemistries and library strategies that preserve biological signal while minimizing artifacts. Moreover, the competitive dynamics among suppliers are shifting as companies prioritize integrated workflow compatibility, service models, and reagent quality assurance. Collectively, these trends are reshaping procurement priorities and accelerating the adoption of modular solutions that can be validated quickly and scaled across heterogeneous lab environments. As a result, organizations must reassess vendor selection criteria, validation timelines, and internal capabilities to capture the benefits of these advances.

Analyzing how US tariff changes and trade policy adjustments in 2025 have increased supply chain friction, procurement complexity, and the prioritization of regional resilience

The cumulative effect of tariff actions and trade policy adjustments in the United States during 2025 has introduced new frictions into global supply chains for sample preparation reagents, plastics, and instrumentation. Elevated import duties and tightened classification requirements have increased landed costs for some hardware components and specialty consumables, prompting procurement teams to revisit supplier diversification, inventory policies, and contractual terms. In parallel, customs compliance has required more granular product coding and documentation, extending lead times for critical items while increasing administrative overhead for both vendors and buyers.

These developments have amplified the operational importance of local distribution partnerships, regional manufacturing footprints, and multi-sourcing strategies. Organizations have responded by prioritizing vendors that maintain regional inventory buffers or that have established manufacturing capacity closer to end markets. In some cases, laboratories have adjusted inventory and ordering cadence to accommodate longer and more volatile lead times, while validation teams have expanded their list of approved equivalencies to reduce single-source risk. Additionally, price negotiation has increasingly factored in total landed cost, including duties and customs-processing expenses, rather than relying solely on list prices.

From a strategic perspective, the tariff-driven environment has accelerated initiatives to simplify supply chains: vendors are consolidating SKUs, offering bundled kits to reduce cross-border transactions, and investing in local service capabilities. For buyers, the imperative is clear-adapt procurement strategies to emphasize supply continuity, contractual flexibility, and vendor transparency. Taken together, these shifts affect capital planning, validation scheduling, and cost-per-assay calculations, and they underscore the importance of supply chain resilience as an integral component of long-term operational planning.

Unpacking a multi-axis segmentation framework that links product types, applications, technologies, workflow steps, and end-user profiles to strategic product and commercialization choices

A coherent segmentation framework reveals the multidimensional nature of the sample preparation landscape and clarifies where innovation and demand are concentrated. When viewed through the lens of product type, the market spans amplification kits, fragmentation and size selection solutions, library preparation kits, and target enrichment kits. Amplification kits encompass conventional PCR approaches as well as digital PCR and qPCR variants, and further include rolling circle amplification with padlock probe and phi29-based methods. Fragmentation and size selection strategies divide into enzymatic fragmentation-distinguishing endonuclease and transposase approaches-and mechanical fragmentation methods such as popular sonication platforms. Library preparation offerings cover RNA-focused workflows (including mRNA, small RNA, and total RNA kits), targeted library approaches for inherited disease and oncology panels, and whole-genome library kits that range from PCR-free to standard WGS preparations. Target enrichment follows a bifurcated path of amplicon-based methods, including multiplex and singleplex PCR, and hybridization-capture strategies that may leverage either array-based or solution-based formats.

Examining segmentation by application further sharpens strategic focus: epigenetics workflows employ bisulfite and ChIP sequencing techniques to interrogate regulatory marks, metagenomics relies on 16S rRNA sequencing and shotgun approaches to profile complex microbial communities, and RNA sequencing spans miRNA, mRNA, and total RNA modalities. Targeted sequencing use-cases emphasize inherited disease, oncology, and pharmacogenomics, reflecting clinical and translational priorities that demand high sensitivity and rigorous validation. Technology segmentation highlights bead-based and enzyme-based chemistries, microfluidic platforms that include droplet and lab-on-chip implementations, and PCR-centric technologies that appear across conventional, digital, and qPCR formats. Finally, evaluating the workflow step perspective clarifies where value is added: amplification, enrichment, fragmentation, library construction, and quantification/quality control each present distinct performance and validation challenges, with quantification increasingly relying on electrophoretic and fluorometric methods. End-user segmentation identifies academic and government research institutions, contract research organizations, diagnostic laboratories, and pharmaceutical and biotechnology companies as the primary adopters, each with different throughput, validation, and procurement requirements.

Taken together, these segmentation layers provide a granular map for product development, go-to-market strategies, and service offerings. They reveal opportunities for suppliers to specialize vertically-for example, by focusing on low-input RNA library chemistry for clinical diagnostics-or to offer modular, validated bundles that reduce buyer validation burden across common workflow steps. This multi-axis view also supports more nuanced commercial conversations with end users, where the intersection of product type, application, and workflow step determines evaluation criteria and procurement timelines.

Exploring how regional supply chain architecture, regulatory regimes, and end-user sophistication shape adoption, support models, and commercialization strategies

Regional dynamics exert a decisive influence on how sample preparation technologies are adopted, regulated, and commercialized. In the Americas, strong academic research capacity and a dense concentration of diagnostic laboratory networks drive demand for both high-throughput automation and specialized kits that support clinical validation. Investment in translational research and a mature private biotech sector incentivize suppliers to provide integrated solutions that ease regulatory submission and laboratory accreditation. In addition, proximity to major manufacturers and regional distribution hubs often shortens lead times and improves after-sales support.

Europe, the Middle East, and Africa display heterogenous adoption patterns driven by differing regulatory regimes, funding models, and healthcare priorities. Western European markets prioritize compliance, reproducibility, and integration with national health systems, motivating suppliers to demonstrate robust quality systems and CE marking or equivalent certifications. Meanwhile, markets across the Middle East and Africa may prioritize cost-effective, ruggedized solutions and localized training and service models. These regional distinctions create opportunities for differentiated go-to-market strategies that account for regulatory complexity, procurement cycles, and local laboratory capacity.

The Asia-Pacific region combines dynamic growth in research infrastructure with rapidly expanding clinical genomics initiatives. Investments in domestic manufacturing and reagent production are notable, driving a mix of locally developed solutions and international partnerships. Differences in regulatory frameworks across countries, varying reimbursement policies, and diverse end-user needs mean that suppliers who can offer adaptable product platforms and local technical support are particularly well-positioned. Across all regions, the overarching theme is that regional supply chain architecture, regulatory expectations, and end-user sophistication jointly shape adoption curves and the design of commercially viable offerings.

Assessing competitive differentiation driven by proprietary chemistries, automation compatibility, service models, and strategic partnerships across the supplier landscape

Competitive dynamics among companies active in sample preparation reflect a balance between deep technical capability, breadth of validated workflows, and the ability to support customers through lifecycle services. Key players differentiate themselves through proprietary chemistries, automation integrations, and quality-control solutions that reduce variability and accelerate validation. Partnerships between reagent providers and instrument manufacturers are increasingly common, yielding bundled solutions that simplify procurement for high-throughput clinical and commercial sequencing labs. At the same time, smaller specialist firms focus on niche chemistries-such as enzyme formulations optimized for low-input or damaged DNA-or on microfluidic systems that enable unique sample handling capabilities.

Investment patterns highlight that companies concentrating on interoperability and open-architecture models can gain traction in environments where buyers prioritize flexibility and vendor neutrality. Conversely, firms that develop closed, fully validated systems appeal to clinical adopters seeking minimal hands-on validation and predictable performance. A further competitive axis centers on service and training: organizations offering on-site method transfer, validation support, and rapid reagent replacement tend to retain higher customer loyalty. Mergers, strategic alliances, and licensing agreements are likely to persist as routes to expand product portfolios and distribution reach, while R&D emphasis on enzyme innovation, low-bias library chemistries, and on-deck automation continues to define technology leadership. In this environment, commercial success depends on a mix of technical excellence, regulatory readiness, and a service-oriented approach that addresses customers' operational constraints.

Prescriptive actions for procurement, R&D, and laboratory leaders to enhance supply resilience, accelerate validation, and optimize technology adoption for sequencing workflows

Leaders in sequencing and sample preparation must adopt a pragmatic, layered strategy that aligns technology choices with operational resilience and scientific objectives. First, procurement teams should expand vendor qualification criteria to include supply chain transparency, regional inventory capabilities, and documented contingency plans, thereby reducing single-source exposure and minimizing validation disruptions. Concurrently, R&D and laboratory directors should prioritize modular workflow validation-opting for component-level equivalency testing where feasible-to accelerate adoption of alternative suppliers without compromising data quality.

Second, invest selectively in automation and closed-system solutions for high-throughput and clinical operations while retaining manual or bench-top flexibility for exploratory and low-volume studies. This hybrid approach balances the throughput and reproducibility gains of automation with the experimental agility needed for method development. Third, cultivate deeper technical partnerships with suppliers that provide co-validation support, method transfer services, and joint training programs; these relationships shorten qualification timelines and improve run-to-run consistency. Fourth, incorporate total landed cost into procurement decision-making, including considerations of tariffs, customs processing, and regional service availability, to ensure commercial decisions reflect operational realities. Finally, create a governance cadence that aligns procurement, compliance, and scientific leadership around validation timelines, change control processes, and inventory policies. Together, these actions enable organizations to maintain scientific rigor, reduce operational risk, and accelerate time-to-insight.

Describing a mixed-methods research approach that integrates stakeholder interviews, technical literature synthesis, and cross-validated product and workflow mapping to ensure robust conclusions

The research approach underpinning this analysis combined structured primary engagement with targeted secondary-source synthesis and rigorous cross-validation. Primary data collection included in-depth interviews with laboratory directors, procurement officers, and technical leads across academic, clinical, and commercial settings to capture operational constraints, validation practices, and technology preferences. These interviews were designed to surface real-world trade-offs between throughput, sensitivity, and hands-on time, and to identify practical mitigation strategies for supply chain disruptions.

Secondary research encompassed technical literature, regulatory guidance, vendor documentation, and publicly available product specifications to map technology features and workflow compatibility. Where possible, product performance characteristics were triangulated across multiple sources to reduce reliance on single-provider claims. The analysis also incorporated case studies of workflow implementations and procurement adaptations to highlight replicable best practices. Data synthesis employed thematic coding to distill recurring challenges and opportunities, and cross-sectional matrices were used to align segmentation layers with end-user requirements.

Limitations are acknowledged: proprietary performance data and unpublished validation studies were not available for all products, and some supplier-specific operational details remain confidential. Nonetheless, the methodology emphasizes reproducibility and transparency, prioritizing observable practices and verifiable documentation while situating findings within broader technological and regulatory trends.

Summarizing why treating sample preparation as a strategic capability is essential for ensuring data integrity, operational resilience, and sustained scientific advancement

In conclusion, sample preparation for next-generation sequencing has evolved from a set of discrete laboratory tasks into a strategic domain that materially affects speed, reproducibility, and the interpretability of sequencing results. Technological advances in enzyme chemistry, fragmentation strategies, microfluidics, and automation are expanding the types of specimens amenable to high-quality sequencing while enabling laboratories to scale operations with reduced variability. Concurrently, trade policy shifts and evolving regional dynamics underscore the operational need for diversified supply chains, regional support, and vendor transparency.

Organizations that proactively align procurement, validation, and scientific strategy will be best positioned to capture the benefits of emerging technologies. Prioritizing multi-sourcing, modular validation, and strategic supplier partnerships can mitigate supply chain risk while preserving scientific flexibility. Ultimately, leaders who treat sample preparation as an integral element of their sequencing strategy-rather than a peripheral commodity-will realize better data quality, faster turnaround, and more reliable outcomes across research and clinical programs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of microfluidic platforms for automated single-cell NGS library preparation to enhance throughput and reduce reagent usage
  • 5.2. Adoption of enzymatic fragmentation kits for streamlined DNA shearing and improved sequencing uniformity in NGS workflows
  • 5.3. Development of magnetic bead-based cleanup systems for high-throughput, scalable NGS library purification and precise size selection
  • 5.4. Implementation of robotics-driven end-to-end NGS sample prep solutions to minimize manual error and accelerate turnaround times
  • 5.5. Emergence of barcoded transposase-based tagmentation methods for cost-effective multiplexed NGS library construction

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. NGS Sample Preparation Market, by Product Type

  • 8.1. Amplification Kits
    • 8.1.1. Pcr Kits
      • 8.1.1.1. Conventional Pcr Kits
      • 8.1.1.2. Digital Pcr Kits
      • 8.1.1.3. Qpcr Kits
    • 8.1.2. Rolling Circle Amplification
      • 8.1.2.1. Padlock Probe Based
      • 8.1.2.2. Phi29 Based
  • 8.2. Fragmentation And Size Selection
    • 8.2.1. Enzymatic Fragmentation
      • 8.2.1.1. Endonuclease Based
      • 8.2.1.2. Transposase Based
    • 8.2.2. Mechanical Fragmentation
      • 8.2.2.1. Bioruptor
      • 8.2.2.2. Covaris
  • 8.3. Library Prep Kits
    • 8.3.1. Rna Library Prep
      • 8.3.1.1. Mrna Kits
      • 8.3.1.2. Small Rna Kits
      • 8.3.1.3. Total Rna Kits
    • 8.3.2. Targeted Library Prep
      • 8.3.2.1. Inherited Disease Panels
      • 8.3.2.2. Oncology Panels
    • 8.3.3. Whole Genome Library Prep
      • 8.3.3.1. Pcr-free Kits
      • 8.3.3.2. Standard Wgs Kits
  • 8.4. Target Enrichment Kits
    • 8.4.1. Amplicon Enrichment
      • 8.4.1.1. Multiplex Pcr
      • 8.4.1.2. Singleplex Pcr
    • 8.4.2. Hybridization Capture
      • 8.4.2.1. Array Based
      • 8.4.2.2. Solution Based

9. NGS Sample Preparation Market, by Application

  • 9.1. Epigenetics
    • 9.1.1. Bisulfite Sequencing
    • 9.1.2. Chip Sequencing
  • 9.2. Metagenomics
    • 9.2.1. 16s Rrna Sequencing
    • 9.2.2. Shotgun Metagenomics
  • 9.3. Rna Sequencing
    • 9.3.1. Mirna Sequencing
    • 9.3.2. Mrna Sequencing
    • 9.3.3. Total Rna Sequencing
  • 9.4. Targeted Sequencing
    • 9.4.1. Inherited Disease
    • 9.4.2. Oncology
    • 9.4.3. Pharmacogenomics
  • 9.5. Whole Genome Sequencing

10. NGS Sample Preparation Market, by Technology

  • 10.1. Bead Based
    • 10.1.1. Magnetic Beads
    • 10.1.2. Solid Phase Beads
  • 10.2. Enzyme Based
    • 10.2.1. Ligase
    • 10.2.2. Restriction Enzyme
    • 10.2.3. Transposase
  • 10.3. Microfluidics
    • 10.3.1. Droplet Based
    • 10.3.2. Lab On Chip
  • 10.4. Pcr Based
    • 10.4.1. Conventional Pcr
    • 10.4.2. Digital Pcr
    • 10.4.3. Qpcr

11. NGS Sample Preparation Market, by Workflow Step

  • 11.1. Amplification
    • 11.1.1. Pcr Amplification
    • 11.1.2. Rolling Circle
  • 11.2. Enrichment
    • 11.2.1. Amplicon
    • 11.2.2. Hybridization
  • 11.3. Fragmentation
    • 11.3.1. Enzymatic
    • 11.3.2. Mechanical
  • 11.4. Library Preparation
    • 11.4.1. Rna Prep
    • 11.4.2. Targeted Prep
    • 11.4.3. Wgs Prep
  • 11.5. Quantification And QC
    • 11.5.1. Electrophoretic
    • 11.5.2. Fluorometric

12. NGS Sample Preparation Market, by End User

  • 12.1. Academic And Government
  • 12.2. Contract Research Organizations
  • 12.3. Diagnostic Laboratories
  • 12.4. Pharma And Biotech

13. NGS Sample Preparation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. NGS Sample Preparation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. NGS Sample Preparation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Illumina, Inc.
    • 16.3.2. Thermo Fisher Scientific Inc.
    • 16.3.3. QIAGEN N.V.
    • 16.3.4. Roche Diagnostics International Ltd.
    • 16.3.5. Agilent Technologies, Inc.
    • 16.3.6. New England Biolabs, Inc.
    • 16.3.7. Takara Bio Inc.
    • 16.3.8. PerkinElmer, Inc.
    • 16.3.9. Bio-Rad Laboratories, Inc.
    • 16.3.10. Promega Corporation
    • 16.3.11. Merck KGaA
    • 16.3.12. BGI Genomics Co., Ltd.
    • 16.3.13. Promega Corporation
    • 16.3.14. Sysmex Corporation
    • 16.3.15. Novogene Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW STEP, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW STEP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NGS SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NGS SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NGS SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL NGS SAMPLE PREPARATION MAR